Ronald M. Paranal

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Jake Delmore, Ghayas C. Issa, Madeleine E. Lemieux et al. · Cell · 2011 · 2.8K citations · Full text

Medicine, Immunology, Therapeutic Efficacy +7

Transcriptional Amplification in Tumor Cells with Elevated c-Myc

Charles Y. Lin, Jakob Lovén, Peter B. Rahl et al. · Cell · 2012 · 1.5K citations · Full text

Tumor Biology, Cell Regulation, Oncogenic Agent +5

NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis

Jonathan D. Brown, Charles Y. Lin, Qiong Duan et al. · Molecular Cell · 2014 · 614 citations · Full text

Inflammation, Inflammatory Disease, Immunology +7

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia

Christopher J. Ott, Nadja Kopp, Liat Bird et al. · Blood · 2012 · 367 citations · Full text

Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition

Oliver Weigert, Andrew A. Lane, Liat Bird et al. · The Journal of Experimental Medicine · 2012 · 161 citations · Full text